From AHA: Coffee Consumption and Atrial Fibrillation, DASH-Patterned Groceries and Effects on Blood Pressure, Oral PCSK9 Inhibitor Enlicitide for Heterozygous Familial Hypercholesterolemia, and more

Special Edition of the JAMA Editor's Summary featuring JAMA Network articles published at the 2025 AHA Scientific Sessions. Hosted by JAMA Executive Editor Gregory Curfman, MD, JAMA Senior Editor Philip Greenland, MD, and JAMA Cardiology Editor Robert O. Bonow, MD, MS. Related Content: Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial HypercholesterolemiaLiberal or Restrictive Postoperative Transfusion in Patients at High Cardiac RiskCaffeinated Coffee Consumption or Abstinence to Reduce Atrial FibrillationDASH-Patterned Groceries and Effects on Blood PressureCoronary Computed Tomography Angiography in Prediction of First Coronary EventsMetformin to Improve Walking Performance in Lower Extremity Peripheral Artery DiseasePhysical Activity and Cardiovascular Outcomes in Phenotype-Negative Cardiomyopathy Variant CarriersEfficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid CardiomyopathyAtorvastatin and Aortic Stiffness During Anthracycline-Based ChemotherapyClonal Hematopoiesis and Incident Heart FailureChronic Kidney Disease Prevalence and Awareness Among US AdultsCardiotoxic Effects of Antibody Drug Conjugates vs Standard Chemotherapy in ERBB2-Positive Advanced Breast CancerPrenatal Care and Perinatal Regionalization for Congenital Heart DefectsLifestyle Intervention for Sustained Remission of Metabolic Syndrome